ipriflavone has been researched along with Lung Diseases, Obstructive in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, J | 1 |
| Kawakatsu, K | 1 |
| Wakayama, T | 1 |
| Sawaoka, H | 1 |
1 other study available for ipriflavone and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Elevation of serum theophylline levels by ipriflavone in a patient with chronic obstructive pulmonary disease.
Topics: Aged; Drug Interactions; Humans; Isoflavones; Lung Diseases, Obstructive; Male; Theophylline | 1992 |